Tandem Diabetes Care Inc
NASDAQ:TNDM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tandem Diabetes Care Inc
NASDAQ:TNDM
|
US |
|
MBB SE
F:MBB
|
DE |
|
M
|
Malee Group PCL
SET:MALEE
|
TH |
|
Interactive Brokers Group Inc
NASDAQ:IBKR
|
US |
|
Nano One Materials Corp
TSX:NANO
|
CA |
|
APQ Global Ltd
LSE:APQ
|
GG |
|
Farmhouse Inc
OTC:FMHS
|
US |
|
Tsumura & Co
TSE:4540
|
JP |
|
4D Molecular Therapeutics Inc
NASDAQ:FDMT
|
US |
|
A
|
Abercrombie & Fitch Co
F:AFT
|
US |
|
S
|
STMicroelectronics NV
XHAM:SGM
|
CH |
|
Custom Truck One Source Inc
NYSE:CTOS
|
US |
|
FreakOut Holdings Inc
TSE:6094
|
JP |
|
Civmec Ltd
SGX:P9D
|
AU |
|
Ionic Rare Earths Ltd
ASX:IXR
|
AU |
|
9 Spokes International Ltd
ASX:9SP
|
NZ |
|
Relevium Technologies Inc
XTSX:RLV
|
CA |
|
I
|
ICC International PCL
SET:ICC
|
TH |
|
Senex Energy Ltd
ASX:SXY
|
AU |
|
K
|
Kook Soon Dang Co Ltd
KOSDAQ:043650
|
KR |
|
T
|
Trajan Group Holdings Ltd
ASX:TRJ
|
AU |
Wall Street
Price Targets
TNDM Price Targets Summary
Tandem Diabetes Care Inc
According to Wall Street analysts, the average 1-year price target for
TNDM
is 31.62 USD
with a low forecast of 21.21 USD and a high forecast of 58.8 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TNDM's stock price target?
Price Target
31.62
USD
According to Wall Street analysts, the average 1-year price target for
TNDM
is 31.62 USD
with a low forecast of 21.21 USD and a high forecast of 58.8 USD.
What is Tandem Diabetes Care Inc's Revenue forecast?
Projected CAGR
11%
For the last 13 years the
compound annual growth rate for
Tandem Diabetes Care Inc's revenue is
59%.
The projected
CAGR
for the next 3 years is
11%.